Related Experiment Videos
Who should be treated with combination therapy as initial treatment for hypertension?
1Department of Preventive Medicine, Rush-Presbyterian-St. Lukes Medical Center, Chicago, IL, USA.
Insights
Combining two antihypertensive agents is recommended for selected patients. Optimal combination strategies are crucial for reducing hypertension-related morbidity and mortality, especially in high-risk populations.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Nephrology
Background:
- Consensus exists on initiating antihypertensive therapy with two agents from different classes.
- Blood pressure targets are agreed upon, but optimal combination strategies for reducing morbidity and mortality are not well-defined.
- Hypertension is heterogeneous, suggesting potential for population-specific treatment strategies.
Purpose of the Study:
- To explore optimal combination strategies for antihypertensive therapy.
- To identify effective regimens for reducing hypertension-related morbidity and mortality.
- To address population-specific approaches for selecting antihypertensive combinations.
Main Methods:
- Review of current consensus and literature on antihypertensive therapy.
- Analysis of factors influencing combination therapy selection.
- Focus on specific patient populations including those with diabetes, renal disease, isolated systolic hypertension, and African Americans.
Main Results:
- Heterogeneity of hypertension necessitates tailored combination strategies.
- Specific populations like those with diabetes, renal disease, and African Americans require individualized approaches.
- Compelling indications should guide initial agent selection, followed by agents to rapidly achieve blood pressure goals.
Conclusions:
- Tailored antihypertensive combination therapy is essential for effective blood pressure management.
- Population-specific strategies are needed to optimize treatment outcomes.
- Prioritizing agents based on compelling indications and rapid goal attainment is key for high-risk patients.
Abstract:
There is currently consensus regarding the need to initiate antihypertensive therapy with a combination of two agents from different antihypertensive classes in selected patients. This consensus extends to the need to bring blood pressure to the appropriate level but has not been defined regarding optimal strategies for selection of combinations that may be most effective at reducing the morbidity and mortality associated with hypertension. Because of the heterogeneous nature of hypertension, there may be unique population-specific strategies for selecting antihypertensive regimens. Appropriate combinations of antihypertensive agents are particularly relevant for patients with diabetes, renal disease, and isolated systolic hypertension as well as for African Americans with high-risk hypertension. The antihypertensive regimen for high-risk patients should be based on those agents for which the patient has compelling indications, with the addition of agents deemed most likely to bring the patient to the appropriate blood pressure goal as quickly as possible.